Paper Details

  1. Home
  2. Paper Details

A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.

Author: ScheinfeldNoah

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Several medications approved for nondermatologic use have proved useful against dermatologic diseases. Deferasirox is effective against porphyria cutanea tarda and hemochromatosis. Bortezomib, a proteasome inhibitor, may be effective against nodular amyloid and squamous cell carcinoma. Dasatinib is likely to be effective against dermatofibroma sarcoma protuberans and cutaneous acute lymphoblastic leukemia. Cyclosporine eye drops are approved to treat dry eyes.
Paper Details　
Original Abstract of the Article :
Recently, a number of medications approved for nondermatologic use have proved useful against dermatologic diseases. This article reviews the dermatologic uses and effects of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops. Deferasirox--an oral iron chelator--could be an effective tre...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/17373201

データ提供：米国国立医学図書館（NLM）

Off-Label Uses of Medications in Cutaneous Medicine: Expanding the Horizons of Treatment

This study explores the potential off-label uses of several medications, originally approved for non-dermatologic conditions, in the treatment of various skin diseases. The researchers review the dermatologic uses and side effects of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops. The study highlights the potential of these medications for treating specific dermatologic conditions, while acknowledging the importance of carefully considering potential side effects.

Expanding the Horizons of Treatment

The study offers a glimpse into the expanding frontiers of dermatologic treatment, exploring the potential of off-label uses of medications. The researchers, like explorers charting a new course across a vast and uncharted desert, have uncovered promising opportunities for treating skin diseases. This research underscores the importance of a nuanced understanding of medication properties and the potential for repurposing existing drugs for new applications.

Expanding the Horizons of Treatment

The study's findings provide a valuable resource for clinicians seeking alternative treatments for dermatologic conditions. The research also emphasizes the importance of careful monitoring and individualization of care when using off-label medications. For patients, the study offers a glimmer of hope for new treatment options, but it’s essential to understand the potential risks and benefits associated with these medications.

Dr. Camel's Conclusion

This study explores the exciting and ever-expanding landscape of dermatologic treatment, revealing new opportunities for using existing medications in innovative ways. The researchers, like desert explorers uncovering hidden treasures, have identified potential off-label uses of medications, expanding the horizons of treatment for skin diseases. This research underscores the importance of ongoing investigation and a willingness to explore new possibilities in the field of medicine.

Date :
  1. Date Completed 2007-04-23
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17373201

DOI: Digital Object Identifier

17373201

Related Literature

Article Analysis
・Side Effects of cyclosporine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.